Effects of Vitamin K2 on the Development of Osteopenia in Rats as the Models of Osteoporosis

참고문헌 (61)

1. "Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR", 278, pp.43919~27 (2003)
2. "Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone", 69, pp.990~1047 (1989)
3. "Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro", 12, pp.431~8 (1997)
4. "Vitamin K", 345, pp.229~34 (1995)
5. "Role of vitamin K in bone metabolism", 15, pp.1~22 (1995)
6. "Vitamin K2 inhibits adipogenesis, osteoclastogenesis, and ODF", RANK ligand expression in murine bone marrow cell cultures, 2000, pp.27, 769~76
7. "Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis", 220, pp.515~9 (1996)
8. "Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro", 16, pp.349~53 (1995)
9. "The inhibitory effect of vitamin K2 (menatetrenone) on bone resorption may be related to its side chain", 16, pp.179~84 (1995)
10. "Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis", 15, pp.515~21 (2000)
11. "Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Study", 117, pp.549~55 (2004)
12. "Combined treatment with vitamin K2 and bisphosphonate in postmenopausal women with osteoporosis", 44, pp.751~6 (2003)
13. "Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG)", 23, pp.41~7 (2005)
14. "Prevention of vertebral fractures with therapeutic agents in corticosteroid-induced osteoporosis", 10, pp.244~7 (2002)
15. "Effects of menatetrenone, a vitamin K analog, on prevention of vertebral fracture in corticosteroid-induced osteoporosis", 16(1), pp.531~ (2001)
16. "Inverse correlation between the changes of lumbar bone mineral density and serum undercarboxylated osteocalcin after vitamin K2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol", 48, pp.11~8 (2001)
17. "Short- term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis", 66, pp.123~8 (2000)
18. "Vitamin K2 inhibits glucocorticoid-induced loss of bone mineral density in patients with chronic glomerulonephritis", 6, pp.123~8 (2000)
19. "Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients", 23, pp.291~6 (1998)
20. "Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency", 31, pp.114~8 (2002)
21. "Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease", 36, pp.61~8 (2005)
22. "Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver", 97, pp.978~81 (2002)
23. "Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women", 91, pp.1769~74 (1993)
24. "Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study", 18, pp.487~8 (1996)
25. "Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study", 82, pp.719~24 (1997)
26. "Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin", 15, pp.2473~8 (2000)
27. "Vitamin K intake and hip fractures in women: a prospective study", 69, pp.74~9 (1999)
28. "Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease", 86, pp.576~81 (2005)
29. "Inhibitory effect of vitamin K2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study", 80, pp.67~74 (1999)
30. "Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized rats", 35, pp.870~80 (2004)
31. "Effect of vitamin K2 on three- dimensional trabecular microarchitecture in ovariectomized rats", 15, pp.1810~7 (2000)
32. "Effect of vitamin K2 on lumbar vertebral bone: histomorphometric analyses in experimental osteoporotic rats", 6, pp.535~9 (2001)
33. "A comparison of alfacalcidol and menatetrenone for the treatment of bone loss on an ovariectomized rat model of osteoporosis", 71, pp.69~79 (2002)
34. "Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats", 30, pp.897~900 (2002)
35. "Regulation of mineral-to-matrix ration of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2", 22, pp.404~14 (2004)
36. "The effect of vitamin K and D supplementation on ovariectomy-induced bone loss", 65, pp.285~9 (1999)
37. "Effect of combined treatment with vitamin K2 and 1α-(OH)-vitamin D3 on bone loss in ovariectomized rats", 118, pp.231~40 (2001)
38. "Bone mass, microstructure, and quality with bone strength-The effects of antiresorptive agents", 12, pp.51~4 (2002)
39. "Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats" (2005)
40. "Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty", 10, pp.1488~95 (1995)
41. "Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover", 82, pp.658~65 (1997)
42. "Long-term effect of testosterone therapy on bone mineral density in hypogonadal men", 82, pp.2386~90 (1997)
43. "Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study", 15, pp.1085~98 (2000)
44. "Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchidectomized rats", 24, pp.491~7 (1999)
45. "Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and", or sciatic neurectomized rats, 2003, pp.18, 776~83
46. "Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats", 31, pp.575~81 (2002)
47. "Effects of menatetrenone on prednisolone-induced bone loss in rats", 14, pp.813~8 (1993)
48. "Menatetrenone prevents osteoblast dysfunction in unilateral sciatic neurectomized rats", 90, pp.88~93 (2002)
49. "Menatetrenone ameliorates reduction in bone mineral density and bone strength in sciatic neurectomized rats", 49, pp.256~61 (2003)
50. "Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy", 76, pp.1721~34 (2005)
51. "of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats", 12, pp.1058~67 (1997)
52. "Comparative effects of intermittent administration of human parathyroid hormone (1-34) on cancellous and cortical bone loss in tail-suspended and sciatic neurectomized young rats", 7, pp.379~85 (2002)
53. "Maintenance of trabecular structure and bone volume by vitamin K2 in mature rats with long-term tail suspension", 20, pp.216~22 (2002)
54. "Inhibition of bone formation during space flight", 201, pp.1138~41 (1978)
55. "Combination use of vitamin K2 further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats", 21, pp.154~60 (2003)
56. "A calcium-deficient diet caused decreased bone mineral density and secondary elevation of estrogen in aged male rats-effect of menatetrenone and elcatonin", 51, pp.1230~4 (2002)
57. "Comparative effect of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium- deficient young rats", 33, pp.557~66 (2003)
58. "Hypercalciuria during experimental vitamin K deficiency in the rat", 37, pp.143~7 (1985)
59. "Effect of menatetrenone (Vitamin K2) on bone mineral density and bone strength in Ca", Mg deficient rats, 2002, pp.120, 195~204
60. "Effects of vitamin K2 (menatetrenone) on calcium balance in ovariectomized rats", 88, pp.55~61 (2002)
61. "Effects of vitamin K2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet", 35, pp.1136~43 (2004)

관련 논문AI추천